As of 2025-06-17, the Intrinsic Value of PMV Pharmaceuticals Inc (PMVP) is -5.86 USD. This PMVP valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.08 USD, the upside of PMV Pharmaceuticals Inc is -642.50%.
Based on its market price of 1.08 USD and our intrinsic valuation, PMV Pharmaceuticals Inc (PMVP) is overvalued by 642.50%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.86 - -5.86 | -5.86 | -642.50% |
| P/E | (15.47) - (31.40) | (24.93) | -2408.3% |
| DDM - Stable | (5.80) - (13.38) | (9.59) | -987.9% |
| DDM - Multi | (4.44) - (8.30) | (5.82) | -638.8% |
| Market Cap (mil) | 56.11 |
| Beta | 0.45 |
| Outstanding shares (mil) | 51.95 |
| Enterprise Value (mil) | 4.76 |
| Market risk premium | 4.60% |
| Cost of Equity | 15.01% |
| Cost of Debt | 5.00% |
| WACC | 10.01% |